Knowledge4COVID-19: A semantic-based approach for constructing a COVID-19 related knowledge graph from various sources and analyzing treatments’ toxicities

Pub Date : 2023-01-01 Epub Date: 2022-10-13 DOI:10.1016/j.websem.2022.100760
Ahmad Sakor , Samaneh Jozashoori , Emetis Niazmand , Ariam Rivas , Konstantinos Bougiatiotis , Fotis Aisopos , Enrique Iglesias , Philipp D. Rohde , Trupti Padiya , Anastasia Krithara , Georgios Paliouras , Maria-Esther Vidal
{"title":"Knowledge4COVID-19: A semantic-based approach for constructing a COVID-19 related knowledge graph from various sources and analyzing treatments’ toxicities","authors":"Ahmad Sakor ,&nbsp;Samaneh Jozashoori ,&nbsp;Emetis Niazmand ,&nbsp;Ariam Rivas ,&nbsp;Konstantinos Bougiatiotis ,&nbsp;Fotis Aisopos ,&nbsp;Enrique Iglesias ,&nbsp;Philipp D. Rohde ,&nbsp;Trupti Padiya ,&nbsp;Anastasia Krithara ,&nbsp;Georgios Paliouras ,&nbsp;Maria-Esther Vidal","doi":"10.1016/j.websem.2022.100760","DOIUrl":null,"url":null,"abstract":"<div><p>In this paper, we present Knowledge4COVID-19, a framework that aims to showcase the power of integrating disparate sources of knowledge to discover adverse drug effects caused by drug–drug interactions among COVID-19 treatments and pre-existing condition drugs. Initially, we focus on constructing the Knowledge4COVID-19 knowledge graph (KG) from the declarative definition of mapping rules using the RDF Mapping Language. Since valuable information about drug treatments, drug–drug interactions, and side effects is present in textual descriptions in scientific databases (e.g., DrugBank) or in scientific literature (e.g., the CORD-19, the Covid-19 Open Research Dataset), the Knowledge4COVID-19 framework implements Natural Language Processing. The Knowledge4COVID-19 framework extracts relevant entities and predicates that enable the fine-grained description of COVID-19 treatments and the potential adverse events that may occur when these treatments are combined with treatments of common comorbidities, e.g., hypertension, diabetes, or asthma. Moreover, on top of the KG, several techniques for the discovery and prediction of interactions and potential adverse effects of drugs have been developed with the aim of suggesting more accurate treatments for treating the virus. We provide services to traverse the KG and visualize the effects that a group of drugs may have on a treatment outcome. Knowledge4COVID-19 was part of the Pan-European <em>hackathon#EUvsVirus</em> in April 2020 and is publicly available as a resource through a <span>GitHub repository</span><svg><path></path></svg> and a <span>DOI</span><svg><path></path></svg>.</p></div>","PeriodicalId":75319,"journal":{"name":"","volume":"75 ","pages":"Article 100760"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558693/pdf/","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"94","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1570826822000440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12

Abstract

In this paper, we present Knowledge4COVID-19, a framework that aims to showcase the power of integrating disparate sources of knowledge to discover adverse drug effects caused by drug–drug interactions among COVID-19 treatments and pre-existing condition drugs. Initially, we focus on constructing the Knowledge4COVID-19 knowledge graph (KG) from the declarative definition of mapping rules using the RDF Mapping Language. Since valuable information about drug treatments, drug–drug interactions, and side effects is present in textual descriptions in scientific databases (e.g., DrugBank) or in scientific literature (e.g., the CORD-19, the Covid-19 Open Research Dataset), the Knowledge4COVID-19 framework implements Natural Language Processing. The Knowledge4COVID-19 framework extracts relevant entities and predicates that enable the fine-grained description of COVID-19 treatments and the potential adverse events that may occur when these treatments are combined with treatments of common comorbidities, e.g., hypertension, diabetes, or asthma. Moreover, on top of the KG, several techniques for the discovery and prediction of interactions and potential adverse effects of drugs have been developed with the aim of suggesting more accurate treatments for treating the virus. We provide services to traverse the KG and visualize the effects that a group of drugs may have on a treatment outcome. Knowledge4COVID-19 was part of the Pan-European hackathon#EUvsVirus in April 2020 and is publicly available as a resource through a GitHub repository and a DOI.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Knowledge4COVID-19:一种基于语义的方法,用于从各种来源构建新冠肺炎相关知识图并分析治疗的毒性
在这篇论文中,我们介绍了Knowledge4COVID-19,这是一个框架,旨在展示整合不同知识来源的力量,以发现新冠肺炎治疗和预先存在的疾病药物之间由药物-药物相互作用引起的不良药物影响。最初,我们专注于使用RDF映射语言从映射规则的声明性定义构建Knowledge4COVID-19知识图(KG)。由于科学数据库(如DrugBank)或科学文献(如CORD-19,新冠肺炎开放研究数据集)的文本描述中存在关于药物治疗、药物相互作用和副作用的有价值信息,因此Knowledge4COVID-19框架实现了自然语言处理。Knowledge4COVID-19框架提取了相关实体和谓词,这些实体和谓词能够对新冠肺炎治疗进行细粒度描述,以及当这些治疗与常见合并症(如高血压、糖尿病或哮喘)的治疗相结合时可能发生的潜在不良事件。此外,除了KG之外,还开发了几种发现和预测药物相互作用和潜在不良反应的技术,目的是为治疗病毒提供更准确的治疗方法。我们提供穿越KG的服务,并可视化一组药物可能对治疗结果产生的影响。Knowledge4COVID-19是2020年4月泛欧黑客马拉松#EUvsVirus的一部分,并通过GitHub存储库和DOI作为资源公开。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1